Gulzhanat N. Nurlanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gulzhanat N. Nurlanova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Zhanna Zhussupova
Department of Neurology and Psychiatry, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan
2 shared publications - A. N. Iskakova
West Kazakhstan Medical University named after Marat Ospanov
1 shared publication - Aigerim B. Utegenova
Department of Neurology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan
1 shared publication - Aigul P. Yermagambetova
WEST KAZAKHSTAN MARAT OSPANOV MEDICAL UNIVERSITY, AKTOBE, REPUBLIC OF KAZAKHSTAN
1 shared publication - Akezhan Astrakhanov
West Kazakhstan Medical University named after Marat Ospanov
1 shared publication - Alima A. Khamidulla
Department of Neurology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
1 shared publication
Latest Publications
- 28 August 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (6) , 471-475
Features of the clinical course of gastroenteritis caused by enteropathogenic Escherichia coli with hemolytic-uremic Gasser syndrome
Enteropathogenic infection caused by Escherichia coli, complicated by hemolytic uremic syndrome (HUS), is rare in adults and is associated with a high risk of severe complications and mortality. We present a clinical case of a 25-year-old patient with acute gastroenteritis complicated by infectious-toxic shock, disseminated intravascular coagulation syndrome, acute kidney injury with anuria, and hemolytic uremic syndrome. The etiological diagnosis was confi rmed by bacteriological stool culture with isolation of enteropathogenic Escherichia coli; tests for salmonellosis and shigellosis were negative. The patient received intensive therapy, including antibacterial treatment, infusion therapy, renal replacement therapy, and correction of coagulopathy. Against the background of comprehensive treatment, gradual recovery of renal function and regression of multiple organ failure were observed. The patient was discharged in satisfactory condition. This case highlights the importance of early diagnosis of hemolytic uremic syndrome in adult patients with severe gastroenteritis and the timely initiation of intensive pathogenetic therapy.
- 28 August 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (6) , 471-475
Features of the clinical course of gastroenteritis caused by enteropathogenic Escherichia coli with hemolytic-uremic Gasser syndrome
Enteropathogenic infection caused by Escherichia coli, complicated by hemolytic uremic syndrome (HUS), is rare in adults and is associated with a high risk of severe complications and mortality. We present a clinical case of a 25-year-old patient with acute gastroenteritis complicated by infectious-toxic shock, disseminated intravascular coagulation syndrome, acute kidney injury with anuria, and hemolytic uremic syndrome. The etiological diagnosis was confi rmed by bacteriological stool culture with isolation of enteropathogenic Escherichia coli; tests for salmonellosis and shigellosis were negative. The patient received intensive therapy, including antibacterial treatment, infusion therapy, renal replacement therapy, and correction of coagulopathy. Against the background of comprehensive treatment, gradual recovery of renal function and regression of multiple organ failure were observed. The patient was discharged in satisfactory condition. This case highlights the importance of early diagnosis of hemolytic uremic syndrome in adult patients with severe gastroenteritis and the timely initiation of intensive pathogenetic therapy.
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Telemedicine and Applications
- Vol. 2025 (1) , 6469893
Bibliometric Analysis of Alpha‐Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson’s Disease
Study Evaluation: The bibliometric analysis of the published results of the alpha‐synuclein ( α ‐syn) detection study in the peripheral tissues of patients with Parkinson’s disease was carried out by us to study scientific activity and scientific productivity, to measure the quantitative and qualitative characteristics of scientific publications, author productivity, and citation of works, as well as the degree of interrelation between authors, journals, institutes, and countries. Purpose: This study is aimed at bibliometrically analyzing the results of studies on the detection of α ‐syn in peripheral tissue biopsy of patients with Parkinson’s disease from 2013 to 2023. Methods: The data was extracted from the Scopus database collection using an inclusive search strategy. Performance analysis and science mapping were conducted using RStudio v.4.3.1 with the bibliometrix R‐package. The analyzed data encompassed trends in publication and citation and the identification of leading institutions, primary sources, authors, and collaborative countries. Results: A total of 124 relevant studies from 53 different sources were thoroughly analyzed. The analysis included the materials of 843 authors, which together gave an impressive average of 37.67 citations per document over the past decade. The annual growth rate in this area of research, according to calculations, was 10.84%, indicating a steady increase in the number of publications over the study period. The huge volume of research results is highlighted by the inclusion of 231 unique keywords of authors. Conclusion: Studies on the detection of pathological α ‐syn in peripheral tissues for early morphological verification of the diagnosis of Parkinson’s disease are relevant in clinical neurology. α ‐syn detected in the skin biopsy of patients on the basis of this study and data from the world literature meets the requirements for biomarkers.
- 1 January 2025
- Published by Wiley in International Journal of Telemedicine and Applications
- Vol. 2025 (1) , 6469893
Open AccessBibliometric Analysis of Alpha‐Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson’s Disease
Study Evaluation: The bibliometric analysis of the published results of the alpha‐synuclein ( α ‐syn) detection study in the peripheral tissues of patients with Parkinson’s disease was carried out by us to study scientific activity and scientific productivity, to measure the quantitative and qualitative characteristics of scientific publications, author productivity, and citation of works, as well as the degree of interrelation between authors, journals, institutes, and countries. Purpose: This study is aimed at bibliometrically analyzing the results of studies on the detection of α ‐syn in peripheral tissue biopsy of patients with Parkinson’s disease from 2013 to 2023. Methods: The data was extracted from the Scopus database collection using an inclusive search strategy. Performance analysis and science mapping were conducted using RStudio v.4.3.1 with the bibliometrix R‐package. The analyzed data encompassed trends in publication and citation and the identification of leading institutions, primary sources, authors, and collaborative countries. Results: A total of 124 relevant studies from 53 different sources were thoroughly analyzed. The analysis included the materials of 843 authors, which together gave an impressive average of 37.67 citations per document over the past decade. The annual growth rate in this area of research, according to calculations, was 10.84%, indicating a steady increase in the number of publications over the study period. The huge volume of research results is highlighted by the inclusion of 231 unique keywords of authors. Conclusion: Studies on the detection of pathological α ‐syn in peripheral tissues for early morphological verification of the diagnosis of Parkinson’s disease are relevant in clinical neurology. α ‐syn detected in the skin biopsy of patients on the basis of this study and data from the world literature meets the requirements for biomarkers.
- 20 December 2024
- Published by Wolters Kluwer Health in West Kazakhstan Medical Journal
- Vol. 66 (4) , 331-342
The Influence of Movement Imitation Therapy on Neurological Outcomes in Children Who Have Experienced Adverse Perinatal Conditions
This study aimed to evaluate the effectiveness of early intervention (EI) for infants at high risk for cerebral palsy (CP), particularly in the context of their neurological development. The study was conducted at the Regional Perinatal Center in Aktobe, Kazakhstan, and included 69 preterm infants with adverse neonatal periods. The infants were divided into two groups: the first group (n=50) began EI at 42 weeks postmenstrual age, while the second group (n=19) started at 52 weeks. Both groups underwent general movements assessment (GMA) and motor activity monitoring using general movement optimality score (GMOS). Results showed that infants receiving EI earlier demonstrated significant improvements in movement quality and a reduced risk of adverse neurological outcomes compared to the control group. The findings highlight the importance of early detection and intervention, as well as the need for implementing early diagnostic programs for infants at risk.
- 20 December 2024
- Published by Wolters Kluwer Health in West Kazakhstan Medical Journal
- Vol. 66 (4) , 331-342
The Influence of Movement Imitation Therapy on Neurological Outcomes in Children Who Have Experienced Adverse Perinatal Conditions
This study aimed to evaluate the effectiveness of early intervention (EI) for infants at high risk for cerebral palsy (CP), particularly in the context of their neurological development. The study was conducted at the Regional Perinatal Center in Aktobe, Kazakhstan, and included 69 preterm infants with adverse neonatal periods. The infants were divided into two groups: the first group (n=50) began EI at 42 weeks postmenstrual age, while the second group (n=19) started at 52 weeks. Both groups underwent general movements assessment (GMA) and motor activity monitoring using general movement optimality score (GMOS). Results showed that infants receiving EI earlier demonstrated significant improvements in movement quality and a reduced risk of adverse neurological outcomes compared to the control group. The findings highlight the importance of early detection and intervention, as well as the need for implementing early diagnostic programs for infants at risk.